Efficacy and safety of fluticasone furoate (FF)/vilanterol (VI) once daily (OD) for 24 weeks in persistent asthma

被引：0
|
作者：
O'Byrne, Paul M. [1 ]
Bleecker, Eugene R. [2 ]
Bateman, Eric D. [3 ]
Busse, William W. [4 ]
Woodcock, Ashley [5 ]
Forth, Richard [6 ]
Toler, Tom [7 ]
Jacques, Loretta [8 ]
Lotvall, Jan [9 ]
机构：
[1] McMaster Univ, Michael G DeGroote Sch Med, Hamilton, ON, Canada
[2] Wake Forest Univ Hlth Sci, Ctr Genom & Personalized Med, Winston Salem, NC USA
[3] Univ Cape Town, Dept Med, Rondebosch, South Africa
[4] Univ Wisconsin, Dept Med, Madison, WI USA
[5] Univ Manchester, Sch Translat Med, Manchester, Lancs, England
[6] GlaxoSmithKline, Quantitat Sci Div, Res Triangle Pk, NC USA
[7] GlaxoSmithKline, Resp Med Dev Ctr, Res Triangle Pk, NC USA
[8] GlaxoSmithKline, Resp Med Dev Ctr, Uxbridge, Middx, England
[9] Univ Gothenburg, Krefting Res Ctr, Gothenburg, Sweden
来源：
EUROPEAN RESPIRATORY JOURNAL | 2012年 / 40卷
关键词：
Treatments; Asthma; -; management;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
3151
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Dose effect of once-daily fluticasone furoate in persistent asthma: A randomized trial
    Bateman, Eric D.
    Bleecker, Eugene R.
    Lotvall, Jan
    Woodcock, Ashley
    Forth, Richard
    Medley, Hilary
    Davis, Angela M.
    Jacques, Loretta
    Haumann, Brett
    Busse, William W.
    RESPIRATORY MEDICINE, 2012, 106 (05) : 642 - 650
  • [22] Efficacy and safety of fluticasone furoate 100 μg once-daily in patients with persistent asthma: A 24-week placebo and active-controlled randomised trial
    Lotvall, Jan
    Bleecker, Eugene R.
    Busse, William W.
    O'Byrne, Paul M.
    Woodcock, Ashley
    Kerwin, Edward M.
    Stone, Sally
    Forth, Richard
    Jacques, Loretta
    Bateman, Eric D.
    RESPIRATORY MEDICINE, 2014, 108 (01) : 41 - 49
  • [23] Spotlight on fluticasone furoate/vilanterol trifenatate for the once-daily treatment of asthma: design, development and place in therapy
    Albertson, Timothy E.
    Bullick, Samuel W.
    Schivo, Michael
    Sutter, Mark E.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 4047 - 4060
  • [24] Lung function effects and safety of fluticasone furoate (FF)/vilanterol (VI) in patients with COPD: Low-mid dose assessment
    Kerwin, Edward M.
    Scott-Wilson, Catherine
    Sanford, Lisa
    Rennard, Stephen I.
    Agusti, Alvar
    Barnes, Neil
    Crim, Courtney
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [25] Lung function effects and safety of fluticasone furoate (FF)/vilanterol (VI) in patients with COPD: Mid-high dose assessment
    Martinez, Fernando
    Boscia, Joseph
    Feldman, Gregory
    Scott-Wilson, Catherine
    Kilbride, Sally
    Fabbri, Leonardi
    Calverley, Peter M. A.
    Crim, Courtney
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [26] Effect of Age on Efficacy and Safety of Fluticasone Furoate/Vilanterol (FF/VI), Umeclidinium (UMEC), and UMEC plus FF/VI in Patients with Chronic Obstructive Pulmonary Disease: Analyses of Five Randomized Clinical Trials
    Hanania, Nicola A.
    Caveney, Scott
    Soule, Tedi
    Tombs, Lee
    Lettis, Sally
    Crim, Courtney
    Mannino, David M.
    Patel, Hitesh
    Boucot, Isabelle H.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2021, 16 : 1925 - 1938
  • [27] Patients with Asthma Prescribed Once-Daily Fluticasone Furoate/Vilanterol or Twice-Daily Fluticasone Propionate/Salmeterol as Maintenance Treatment: Analysis from a Claims Database
    Atsuta R.
    Takai J.
    Mukai I.
    Kobayashi A.
    Ishii T.
    Svedsater H.
    Pulmonary Therapy, 2018, 4 (2) : 135 - 147
  • [28] Efficacy and safety of ciclesonide once daily and fluticasone propionate twice daily in children with asthma
    Pedersen, Soren
    Engelstaetter, Renate
    Weber, Hans-Jochen
    Hirsch, Sabine
    Barkai, Laszlo
    Emeryk, Andrej
    Weber, Heinrich
    Vermeulen, Jan
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2009, 22 (03) : 214 - 220
  • [29] Efficacy and safety comparison: Fluticasone furoate and fluticasone propionate, after step down from fluticasone furoate/vilanterol in Japanese patients with well-controlled asthma, a randomized trial
    Adachi, Mitsuru
    Goldfrad, Caroline
    Jacques, Loretta
    Nishimura, Yoshie
    RESPIRATORY MEDICINE, 2016, 120 : 78 - 86
  • [30] Safety of fluticasone furoate (FF), an inhaled corticosteroid in combination with vilanterol (VI), a long-acting beta agonist in management of COPD exacerbations
    Calverley, Peter M. A.
    Dransfield, Mark T.
    Bourbeau, Jean
    Jones, Paul
    Hanania, Nicola A.
    Mahler, Donald A.
    Vestbo, Jorgen
    Wachtel, Andrew
    Martinez, Fernando
    Barnhart, Frank
    Sanford, Lisa
    Lettis, Sally
    Crim, Courtney
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
12345